The markets are up slightly ahead of the bell, as Trump’s first 100 days come to a close this Saturday. U.S. economic data was released this morning, which included: Durable Goods Orders, and the month over month change in New Orders came in lighter than expected; International Trade in Goods numbers were released, and the Balance came in at ($64.8B), while the consensus estimate was ($65.3B), as exports and imports changes were negative; and New Jobless Claims came in at 257K, while the consensus estimate was 244K. Now that you’re caught up with the markets, traders are looking at these stocks to trade on April 27, 2017.
Sapiens International (NASDAQ: SPNS) shares are down nearly 10% in the premarket, after the company announced it expects to see lower revenues than initially anticipated. This could stem from the company halting a recent project– over a contract dispute.
It has cut its 2017 revenue guidance to $265M to $275M, which is a drop from the previous range of $270M to $280M. In addition, the company expects full operating profit margin to be between 9% and 10%, a drop from previous guidance, which was around 13%.
This stock on average doesn’t trade more than about 50K shares per day, but has traded over 30% of that volume in the premarket today.
Check out the chart of SPNS below:
EuroTech Holdings Company (NASDAQ: CLWT) shares are up over 50% in the premarket, after the company announced earnings results. According to a press release, here are some of the company highlights:
The Company’s revenues for Fiscal 2016 were approximately $22,478,000, an approximate 22.8% increase compared to approximately $18,302,000 in the Company’s fiscal year ended December 31, 2015 (“Fiscal 2015”).
The Company had net profit of approximately US$231,000 in Fiscal 2016 as compared to net loss of approximately US$616,000 in Fiscal 2015. This was primarily due to increase in revenue, decrease in selling and administrative expenses and increase in profit contribution from affiliates.
Source: PR Newswire
This stock on average only trades less than 8K shares per day; however, it had already doubled that amount before 8 AM ET, and has a float of less than 1m shares
Check out the chart of CLWT below:
Ultra Clean Holdings (NASDAQ: UCTT) shares are up over 14% in the premarket, after another announcing Q1 2017 financial results. In fact, this marked the fifth straight quarter it has outperformed.
Here are some of it’s highlights:
GAAP Financial Results
Total revenue for the first quarter of 2017 was $204.6 million, an increase of 17.2% compared to the fourth quarter of 2016 and 82.3% compared to the same period a year ago. Semiconductor revenue increased 22.4% compared to the fourth quarter of 2016 and 80.4% compared to the same period a year ago. Total revenue from outside the U.S. rose 17.7% sequentially and 115.0% compared to the same period a year ago. Gross margin for the first quarter of 2017 was 18.3% compared to 17.0% for the prior quarter and 13.0% for the same period a year ago. Net income for the first quarter was $14.3 million, or $0.43 and $0.42 per basic and diluted share compared to net income of $10.0 million, or $0.30 per basic and diluted share in the previous quarter, and net loss of $3.2 million, or $0.10 per basic and diluted share for the same period a year ago.
Source: 8-K filing
The company also received a reiterated buy rating from Needham, and a price target of 22.
Check out the chart of UCTT below:
Medigus (NASDAQ: MDGS) shares are up over 20%, after the company announced it has completed 10 procedures with the China Food and Drug Administration.
This is what the company said in its 6-K filing:
“The availability of the MUSE™ procedure in China provides patients with a less invasive option for the long-term treatment of GERD,” said principal investigator, Yunsheng Yang, Director of Gastroenterology Department Clinical center at 301 Hospital and chairman of Chinese Society of Gastroenterology, The General Hospital of People’s Liberation Army in Beijing. “The procedure addresses a new hope and solution between drug therapy and surgical procedures.”
This is still the initial stage but the company seems optimistic, and so are traders. On average, this stock might see 60K shares trade; however, over 350K shares have traded on this ultra low float stock.
Check out the chart of MDGS below:
Altisource Portfolio (NASDAQ: ASPS) shares are up a modest 4% in the premarket, after the company announced its Q1 2017 results. The company beat EPS by $0.45 compared to what the Capital IQ Consensus had.
Here are some of the highlights from the company’s 8-K filing:
“I’m pleased with our first quarter financial performance. Compared to the mid-point of our full year 2017 scenarios, first quarter 2017 service revenue is 27% of the mid-point and adjusted diluted earnings per share(1)is 24% of the mid-point. Since our second and third quarters are historically our seasonally strongest, we believe we’re positioned to achieve the mid-point of our 2017 service revenue and adjusted earnings per share financial scenarios,” said Chief Executive Officer William B. Shepro.
Check out the chart below of ASPS: